End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.3 TWD | +2.47% | +3.88% | -12.26% |
17/04 | Eusol Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Eusol Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hong Jen Chang
CEO | Chief Executive Officer | 68 | 05/09/05 |
Chun Yue Lin
DFI | Director of Finance/CFO | - | - |
Wan Ya Chang
BRD | Director/Board Member | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shih Chang Hsu
BRD | Director/Board Member | 61 | - |
Hong Jen Chang
CEO | Chief Executive Officer | 68 | 05/09/05 |
Tsung Jen Yang
BRD | Director/Board Member | - | 15/18/15 |
Weng Foung Huang
BRD | Director/Board Member | - | 15/18/15 |
Hung Mo Li
BRD | Director/Board Member | - | 15/18/15 |
Wan Ya Chang
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 137,000,000 | 92,100,000 ( 67.23 %) | 0 | 67.23 % |
Company contact information
Eusol Biotech Co., Ltd.
6/F, No. 135, Section 3 Minsheng East Road
105 44, Taipei
+
http://www.eusol.com.twSector
1st Jan change | Capi. | |
---|---|---|
-12.26% | 34.87M | |
+54.61% | 811B | |
+43.76% | 640B | |
-6.33% | 353B | |
+20.62% | 333B | |
+10.44% | 302B | |
+18.11% | 246B | |
+2.66% | 225B | |
+12.90% | 218B | |
+8.61% | 168B |
- Stock Market
- Equities
- 6652 Stock
- Company Eusol Biotech Co.,Ltd.